More Anatara Lifesciences Ltd news
Anatara Lifesciences LtdASX: ANR

Appendix 4D & Half Year Report 31 December 2023

Feb 28, 2024 at 1:13 AM EST · Issued by Anatara Lifesciences Ltd

Filed with ASX · Feb 28, 2024 at 1:13 AM EST

On 6ix: 6ix.com/news/appendix-4d-and-half-year-report-31-december-2023-3

Anatara Lifesciences Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Anatara Lifesciences Ltd on 6ix

Story so far

  • Half Yearly Report and AccountsFeb 24, 2023
  • Half Year AccountsFeb 24, 2022

Earlier from Anatara Lifesciences

  • Appendix 4C & Q2 FY24 Activities ReportJan 23, 2024
  • Entitlement Offer ResultsDec 6, 2023
  • Non-Renounceable Entitlement Offer BookletNov 13, 2023
  • Entitlement offer opens and dispatch of Offer BookletNov 13, 2023
  • AGM Chair AddressNov 9, 2023

Later from Anatara Lifesciences

  • Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2Feb 29, 2024
  • Anatara successful placement for $1.0MMay 1, 2024
  • Appendix 4C & Q4 FY24 Activities ReportJul 30, 2024
  • Appendix 4E & Financial Report 30 June 2024Aug 22, 2024
  • $626,000 received in R&D Tax Incentive for FY24Aug 28, 2024
All Anatara Lifesciences news releases↗

Follow Anatara Lifesciences into a list and get an email when it puts out news.

Follow Anatara Lifesciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer